Merger and Acquisitions Review: Unilever Shops Skippy, Microsoft Buys PhoneFactor

Unilever (NYSE:UL) is thinking of selling its Skippy peanut butter brand for a price between $300 million and $400 million, say sources. Analyst Bryan Gildenberg thinks the move makes sense because it meets the company strategy of positioning itself more as a personal care company than a food business.

BioSante Pharmaceuticals (NASDAQ:BPAX) will merge with ANI Pharmaceuticals in an all-stock transaction with the former as the surviving entity. Upon conclusion, BioSante shareholders will keep approximately 47 percent.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>

The Israeli medical device firm Given Imaging (NASDAQ:GIVN) purchases the SmartPill GI Monitoring System from The SmartPill Corporation, which is based in the United States, for a price of $6 million. The SmartPill is an ingestible capsule which utilizes sensor tech to measure pH, pressure and temperature in the gastrointestinal tract and is also used to evaluate motility disorders such as gastroparesis and constipation.

Microsoft Corporation (NASDAQ:MSFT) has bought PhoneFactor, which supplies enterprise authentication services. The buyer intends to join PhoneFactor’s solutions which act as an alternative to hardware-based security tokens with its business applications and cloud services.

Don’t Miss: Here’s the Apple Deal That Samsung Rejected.